Soralieva 200mg

Soralieva 200mg Tablet is classified as a multikinase inhibitor cancer medication that contains sorafenib as its active ingredient. This tablet is primarily utilized for treating advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and thyroid cancer.

If you are allergic to sorafenib or any other components of this medication, it is not advisable to take Soralieva 200mg Tablet. If you notice any skin rashes, heart issues, chest pain, bleeding problems, high blood pressure, or if you have had or are planning to have surgery, consult your doctor immediately. This medication is not recommended for children and adolescents. Patients with diabetes should regularly check their blood sugar levels to determine if adjustments to their anti-diabetic medications are necessary to prevent low blood sugar. Your doctor will also monitor liver function tests, as well as fluid and electrolyte balance, to quickly identify and manage any potential side effects.

Using this medication during pregnancy is not recommended as it may pose risks to the fetus. Therefore, women of reproductive age should take a pregnancy test before starting this treatment. It is advisable to continue using birth control for at least six months after completing the treatment. Additionally, breastfeeding is not recommended while undergoing this treatment, as it may impact your baby’s growth and development. This therapy may also affect fertility in both men and women, so it is important to consult your doctor prior to starting the treatment.

Make sure to inform your doctor about all medications you are currently taking, including prescription drugs, over-the-counter medications, vitamins, and supplements.